New blood thinner may beat aspirin for aneurysm patients

NCT ID NCT07089862

Recruiting now Disease control Sponsor: Beijing Tiantan Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests if a drug called indobufen works better than aspirin at preventing strokes and blood clots after a brain aneurysm is fixed with a stent or coil. About 2,500 people with unruptured brain aneurysms will take either indobufen or aspirin, plus clopidogrel, for 6 months after their procedure. Researchers will track strokes, bleeding, and other complications to see which regimen is safer and more effective.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UNRUPTURED INTRACRANIAL ANEURYSM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain aneurysm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INDOBUFEN UNRUPTURED INTRACRANIAL ANEURYSM

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Capital Medical University Affiliated Beijing Tiantan Hospital
RECRUITING

Beijing, Beijing Municipality, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact